By
Drug Target Review2025-07-07T13:30:05
Shift Bioscience has published a new study introducing enhanced metrics and baselines for evaluating virtual cell models - boosting gene target discovery and accelerating its rejuvenation therapeutics pipeline.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2023-05-31T15:16:10
Sponsored by Bio-Techne
Site powered by Webvision Cloud